Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR’) including circulars issued thereunder and other applicable provisions, if any, as amended from time to time, and in continuation to its intimation dated 30th June, 2026, Arvaya Healthcare has informed that the Board of Directors of the Company at its meeting held today Saturday, July 4, 2026 commenced at 11:30 am (IST) and concluded at 11:45 am (IST) has, considered and approved the following matters: 1. Based on the recommendation of Nomination & Remuneration Committee, approved the appointment of Bidari Kotresh Anilkumar (DIN: 06624790) as an Additional Director designated as Executive Director of the Company with effect from 4th July, 2026 and subject to the approval of the Members of the Company by way of Ordinary Resolution, for a term of three years liable to retire by rotation. In accordance with the circular dated 20th June, 2018 issued by the Stock Exchanges, it has confirmed that Bidari Kotresh Anilkumar (DIN: 06624790) is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other regulatory authority. The requisite disclosures as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular no. SEBI/ HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January, 2026 are provided in Annexure-A. The meeting of the Board of Directors commenced at 11:30 am (IST) and concluded at 11:45 am (IST).
